Rize Oncology Inc.
RZONF
$0.16
$0.159639,900.00%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -31.11% | 20.28% | -6.31% | -17.68% | -8.13% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 637.29% | -39.16% | -32.06% | 4,786.67% | -96.83% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -14.12% | 17.36% | -8.02% | -11.94% | -11.10% |
|
|||||
Total Current Assets | -14.12% | 17.36% | -8.02% | -11.94% | -11.10% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -14.12% | 17.36% | -8.02% | -11.94% | -11.10% |
|
|||||
Total Accounts Payable | -57.84% | 171.09% | 26.72% | -57.74% | 73.73% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -59.57% | 182.65% | 26.72% | -57.74% | 42.23% |
|
|||||
Total Current Liabilities | -59.57% | 182.65% | 26.72% | -57.74% | 42.23% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -59.57% | 182.65% | 26.72% | -57.74% | 42.23% |
|
|||||
Common Stock & APIC | 8.41% | 0.01% | 0.34% | 0.03% | 0.06% |
Retained Earnings | -5.49% | -3.65% | -2.84% | -2.44% | -3.37% |
Treasury Stock & Other | -397.81% | 142.33% | 6.34% | -5.94% | -18.30% |
Total Common Equity | -10.72% | 12.44% | -8.77% | -9.84% | -12.61% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -10.72% | 12.44% | -8.77% | -9.84% | -12.61% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -10.72% | 12.44% | -8.77% | -9.84% | -12.61% |
|